Removing the Stigma of Addiction

March 9, 2022

Article

How can we move toward a culture of education and empowerment?

“There are a lot of ways that we can step us as a community, as friends, and as clinicians to really understand and check our views on addiction.” In this Mental Health Minute video, Alex Colyer, founder and president of The Albertus Project, discusses how The Albertus Project focuses on education and empowerment to transform the world’s perception of addiction from blame and shame to compassion and support.

Ms Colyer is the founder and president of The Albertus Project, a 501(c)(3) nonprofit organization.

Related Videos

“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”

Work takes up one-third of a patient’s life—it is important that we pay attention to it.

A new treatment in development is poised to be a game-changer for patients with postpartum depression.

An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.

Related Content

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 2 of their conversation.

Long-Acting Injectable vs Oral Antipsychotics: Part 2 of a Conversation With Peter J. Weiden, MD

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.

Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD

The Psychiatric Times Substance Use Section Editor reflects on the theme of the 2024 Annual Meeting, plus what he is most excited about in psychiatry.

The Role of Addiction in Treatment Plans and Outcomes

Philip R. Muskin, MD, MA, DLFAPA, LFACLP, discusses contemporary psychiatry and some of the most exciting things about the 2024 Annual Meeting.

The 3 Biggest Challenges in Psychiatry Today

Rikinkumar Patel, MD, MPH, shares some recent research findings with Psychiatric Times at the 2024 Annual Meeting.

The Inpatient Setting vs the Time of the Year in Hospitalized Child and Adolescent Patients

How does artificial intelligence have the potential to shape the future of psychiatry?

Making Sense of Chatbots

Related Content

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 2 of their conversation.

Long-Acting Injectable vs Oral Antipsychotics: Part 2 of a Conversation With Peter J. Weiden, MD

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.

Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD

The Psychiatric Times Substance Use Section Editor reflects on the theme of the 2024 Annual Meeting, plus what he is most excited about in psychiatry.

The Role of Addiction in Treatment Plans and Outcomes

Philip R. Muskin, MD, MA, DLFAPA, LFACLP, discusses contemporary psychiatry and some of the most exciting things about the 2024 Annual Meeting.

The 3 Biggest Challenges in Psychiatry Today

Rikinkumar Patel, MD, MPH, shares some recent research findings with Psychiatric Times at the 2024 Annual Meeting.

The Inpatient Setting vs the Time of the Year in Hospitalized Child and Adolescent Patients

How does artificial intelligence have the potential to shape the future of psychiatry?

Making Sense of Chatbots

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.